These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6650494)

  • 1. Increased serum procollagen III aminoterminal peptide in myelofibrosis.
    Hochweiss S; Fruchtman S; Hahn EG; Gilbert H; Donovan PB; Johnson J; Goldberg JD; Berk PD
    Am J Hematol; 1983 Dec; 15(4):343-51. PubMed ID: 6650494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
    Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
    Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
    Arrago JP; Poirier O; Najean Y
    Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum procollagen III peptide in chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD
    Scand J Haematol; 1985 Nov; 35(5):550-7. PubMed ID: 4089533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levels of procollagen type III n-terminal peptide (PIIINP) in serum of patients with myeloproliferative syndrome (mps)].
    Podolak-Dawidziak M; Wróbel T; Jeleń M
    Pol Arch Med Wewn; 1998 Jan; 99(1):24-9. PubMed ID: 9686500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum.
    Abildgaard N; Bendix-Hansen K; Kristensen JE; Vejlgaard T; Risteli L; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Dec; 99(3):641-8. PubMed ID: 9401078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP).
    Taube T; Franssila K; Risteli L; Risteli J; Elomaa I
    Br J Haematol; 1992 Sep; 82(1):32-7. PubMed ID: 1419800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis.
    Vellenga E; Mulder NH; van Zanten AK; Nieweg HO; Woldring MG
    Eur J Nucl Med; 1983; 8(11):499-501. PubMed ID: 6653612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
    Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
    Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia.
    Barosi G; Costa A; Liberato LN; Polino G; Spriano P; Magrini U
    Br J Haematol; 1989 May; 72(1):16-20. PubMed ID: 2736239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1 alpha(OH)D3 treatment and procollagen III (PC III) studies in idiopathic myelofibrosis.
    Tsatalas C; Curtoglou G; Fotopoulos D; Halkia P; Vyzantiadis AT; Sinakos Z
    Haematologica; 1989; 74(6):559-62. PubMed ID: 2628238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.
    Ghanima W; Junker P; Hasselbalch HC; Boiocchi L; Geyer JT; Feng X; Gudbrandsdottir S; Orazi A; Bussel JB
    Br J Haematol; 2011 Oct; 155(2):248-55. PubMed ID: 21902682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers for type IV collagen and type III procollagen in the myelofibrosis-osteomyelosclerosis syndrome and other chronic myeloproliferative disorders.
    Hasselbalch H; Junker P; Lisse I; Bentsen KD; Risteli L; Risteli J
    Am J Hematol; 1986 Oct; 23(2):101-11. PubMed ID: 3752065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Hilgarth M; Hubmann R; Duechler M; Gisslinger H
    J Clin Invest; 2004 Mar; 113(5):676-85. PubMed ID: 14991065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum pro-collagen III in chronic myeloproliferative disorders.
    Najean Y; Legrand M; Poirier O; Senechal A; Arrago JP
    Eur J Haematol; 1990 Nov; 45(5):239-43. PubMed ID: 2261948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum procollagen-III-peptide as a marker for primary myelofibrosis: effect of anthracyclin.
    Parmentier C; Schlumberger M; Caillou B; Boaziz C
    Eur J Haematol; 1987 Nov; 39(5):475. PubMed ID: 3480241
    [No Abstract]   [Full Text] [Related]  

  • 17. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.
    Jensen MK; Riisbro R; Holten-Andersen MN; Brown Pde N; Junker P; Brünner N; Hasselbalch HC
    Eur J Haematol; 2003 Oct; 71(4):276-82. PubMed ID: 12950237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive prolyl hydroxylase in patients with primary and secondary myelofibrosis.
    Wang JC; Wong C; Kao WW
    Br J Haematol; 1987 Feb; 65(2):171-4. PubMed ID: 3030390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of determining the amino terminal fragment of procollagen III in myeloproliferative disorders].
    Najean Y; Poirier O; Arrago JP
    Nouv Rev Fr Hematol (1978); 1987; 29(2):123-7. PubMed ID: 3615194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis.
    Apaja-Sarkkinen M; Autio-Harmainen H; Alavaikko M; Risteli J; Risteli L
    Br J Haematol; 1986 Jul; 63(3):571-80. PubMed ID: 3524658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.